News

A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer's disease, which was previously thought to be undruggable.

A team of researchers has designed a new approach that combines multicomponent reactions with domino type processes to ease the synthesis of structurally complex molecules.

Despite intensive research efforts, there is no cure for COPD. Current therapies focus on relieving symptoms and reducing the progression of the disease. A recent study shows promising results for treating COPD.

In a small study of adults diagnosed with major depression, researchers report that two doses of psilocybin, administered with supportive psychotherapy, produced rapid and large reductions in depressive symptoms.

Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they're extracted from llamas and camels, which is problematic for a number of reasons. Now, scientists have identified a synthetic form of a nanobody, known as a sybody, which shows affinity to SARS-CoV-2 and neutralizing capabilities.

Using artificial intelligence, UCPH researchers have solved a problem that until now has been the stumbling block for important protein research into the dynamics behind diseases such as cancer, Alzheimer's and Parkinson's, as well as in the development of sustainable chemistry and new gene-editing technologies.

Johns Hopkins researchers have designed microdevices that can latch onto intestinal mucosa and release drugs into the body.

Beta-blockers could potentially be used to treat COVID-19, according to a new international study led by Italian and Australian researchers.

Two scientists at the Max Planck Institute of Neurobiology developed a method in the fruit fly that marks receptor proteins in selected cells. In this way, they gained new insights into the neuronal mechanisms of motion vision. In addition, the research community receives an innovative tool to label proteins of all kinds.

A team of biomedical engineers has studied how human and mouse cells communicate with each other. The team discovered that the humanized tissue is physiologically integrated into single functional bone tissue which retains species-specific ultrastructural differences.